Vincenzo De Geronimo
Overview
Explore the profile of Vincenzo De Geronimo including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
10
Citations
74
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Di Stasi V, La Sala D, Cozzi R, Scavuzzo F, De Geronimo V, Poggi M, et al.
Cancers (Basel)
. 2025 Feb;
17(3).
PMID: 39941803
Immune checkpoint inhibitors (ICIs) have revolutionized oncology, providing a groundbreaking therapeutic option for patients with various advanced-stage cancers. While these treatments can significantly extend survival, they also carry a substantial...
2.
Lisco G, De Tullio A, De Geronimo V, Giagulli V, Guastamacchia E, Piazzolla G, et al.
Biomedicines
. 2024 Aug;
12(8).
PMID: 39200316
Background: One hundred years have passed since the discovery of insulin, which is one of the most relevant events of the 20th century. This period resulted in extraordinary progress in...
3.
Lisco G, Disoteo O, De Tullio A, De Geronimo V, Giagulli V, Monzani F, et al.
Nutrients
. 2024 Jan;
16(1).
PMID: 38201893
Sarcopenia is an age-related clinical complaint characterized by the progressive deterioration of skeletal muscle mass and strength over time. Type 2 diabetes (T2D) is associated with faster and more relevant...
4.
Lisco G, Accardo G, Pupilli C, Malandrino P, De Geronimo V, Triggiani V
Endocrine
. 2024 Jan;
85(1):1-10.
PMID: 38195966
Introduction: Perchlorates are ionic inhibitors antagonizing iodine transport into thyrocytes, hampering thyroid hormone synthesis. Nevertheless, perchlorates are not considered as first-line treatment in hyperthyroidism and thyrotoxicosis as compared to other...
5.
Lisco G, De Tullio A, Disoteo O, Piazzolla G, Guastamacchia E, Sabba C, et al.
Endocr Connect
. 2023 Sep;
12(11).
PMID: 37656509
Glucagon-like peptide 1 receptor agonists (GLP-1RAs) have changed considerably the management of type 2 diabetes (T2D). However, recently published data from retrospective cohort studies suggest that chronic exposure to GLP-1RAs...
6.
Lisco G, De Tullio A, Disoteo O, De Geronimo V, Piazzolla G, De Pergola G, et al.
Front Endocrinol (Lausanne)
. 2022 Sep;
13:920541.
PMID: 36157450
Tirzepatide, a dual agonist of Glucose-Dependent Insulinotropic Polypeptide (GIP) and Glucagon-Like Peptide 1 (GLP-1) receptors, improved glucose control and reduced body weight in different therapeutic approaches. Herein, we overviewed the...
7.
Vescini F, Chiodini I, Falchetti A, Palermo A, Salcuni A, Bonadonna S, et al.
Int J Mol Sci
. 2021 Dec;
22(24).
PMID: 34948434
Male osteoporosis is a still largely underdiagnosed pathological condition. As a consequence, bone fragility in men remains undertreated mainly due to the low screening frequency and to controversies in the...
8.
Loscalzo Y, Marucci S, Garofalo P, Attanasio R, Lisco G, De Geronimo V, et al.
Endocr Metab Immune Disord Drug Targets
. 2021 Jul;
21(12):2238-2252.
PMID: 34303333
Background: Some endocrinologists were involved in the management of patients with suspected or confirmed COVID-19 during the first wave of the pandemic. This study aims to analyze burnout levels among...
9.
De Geronimo V, Cannarella R, La Vignera S
Endocr Metab Immune Disord Drug Targets
. 2021 Jan;
21(11):1954-1960.
PMID: 33461477
Background: Thyroid disease and obesity are widespread clinical conditions in the population. They can occur together in the same subject, but their relationship does not seem exclusively stochastic. Aim: Literature...
10.
Castorina S, Barresi V, Luca T, Privitera G, De Geronimo V, Lezoche G, et al.
Int J Obes (Lond)
. 2020 Nov;
45(1):184-194.
PMID: 33230309
Background/objectives: Distribution and activity of ghrelin cells in the stomach of obese subjects are controversial. Subjects/methods: We examined samples from stomachs removed by sleeve gastrectomy in 49 obese subjects (normoglycemic,...